NNNeville S. Ng

Neville S. Ng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Neville S. Ng has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Editorial: Recent advances in mitochondrial dysfunction and therapeutics for neurodegeneration and aging

    by Monokesh K. Sen, Keagan Dunville, Nicole Miles, Michelle Newbery, Neville S. Ng, Lezanne Ooi

    Recent estimates indicate that neurological conditions affect over 3.4 billion individuals globally (Steinmetz et al., 2024). A well-established contributor to neurological conditions is the decline of mitochondrial function, responsible for producing over 90% of cellular ATP via oxidative phosphorylation. Mitochondrial dysfunction is closely linked to cellular pathology, and cognitive and motor decline symptoms in neurodegeneration and aging. Common features of mitochondrial dysfunction include excessive reactive oxygen species (ROS) generation, damage to mitochondrial DNA (mtDNA), impaired mitochondrial quality control, and disrupted mitochondrial dynamics (Ng et al., 2024). Subsequent cellular damage includes disrupted protein synthesis, transport, and degradation, increased inflammation, oxidative damage to genomic DNA, lipids, and proteins, aberrant calcium signalling, telomere shortening, senescence, eventual cell death (Ng et al., 2024), contributing to complex protein-nucleic acid mass aggregation and systemic inflammation. Submissions to this Special Topic collection exemplify a range of experimental approaches to analyse mitochondrial aetiology in neurological disorders and aging (Figure 1). These studies highlight the significance of mitochondrial damage, dysfunctional mitochondrial biogenesis and mito-lysosomal clearance, and subsequent neuroinflammation in neurodegenerative diseases and aging, discussed in concluding notes of this editorial. Using iPSC neuronal models with microfluidics to analyse LRRK2 mutation in Parkinson's disease Valderhaug et al. (2024) explored a pilot of a multichambered microfluidic slide and microelectrode arrays, using a Parkinson's disease induced pluripotent stem cell (iPSC) derived line with a LRRK2 G2019S mutation, associated with both familial and sporadic forms, compared against its isogenic control. This combination allowed for the structuring of intrinsic network firing behaviour, mitochondrial membrane potential, kymography, and oxidative stress, with and without the ionotropic glutamate agonist kainic acid. Neurons with the LRRK2 G2019S mutation showed greater neurite outgrowth, increased mitochondrial motility that was decreased with kainic acid stress, decreased mitochondrial anterograde movement, and hyperpolarisation in LRRK2 G2019S networks. While limited to preliminary observations in replicate number, these data demonstrate a multimodal approach to simultaneously analysing neurite density, electrophysiology and mitochondria, that could be applied to other disease models. Mitochondria play a pivotal role in neurodevelopment, and in this special topic collection, several groups investigate the role of mitochondria in sensory and associative cortical systems. Cavestro et al. (2024) investigate the role of Coenzyme A synthase (protein: CoA synthase, encoding gene: Coasy, Chr:11) in mouse in vitro and in vivo knockout models to dissect nuclear-mitochondrial crosstalk relevant to CoA-related disorders. CoA synthase lossof-function mutations drive rare yet debilitating neurodegeneration, such as Coasy proteinassociated neurodegeneration, and neurodevelopmental disorders, including Pontocerebellar Hypoplasia Type 12. Conditional knockouts were generated using a humanised glial fibrillary acidic protein (GFAP) promoter and Coasy flox/flox mice, ensuring loss of CoA synthase in astroglial lineage cells. Intriguingly, GFAP-Coasy mice manifested two distinct, sexindependent phenotypes with motor deficits: early onset (euthanized by postnatal day 20) and late onset (unaffected mortality). Additionally, GFAP-Coasy mice exhibited severe layering deficits in the cortex and cerebellum, demonstrating that embryonic expression of CoA synthase is necessary for inherent cytoarchitectural establishment. Moreover, astroglialspecific expression of nuclear receptor coactivator 4 was decreased, coincident with increased lipid peroxidation and decreased mitochondrial respiration in GFAP-Coasy-derived primary astrocytes. Given that astroglial populations do not fully mature until postnatal weeks 3-4 in mice, deficits in astroglial cells are likely latent and do not fully account for lamination deficits.However, GFAP is also expressed by neural stem cells, thus deletion of CoA synthase may have occurred across all neural cell types, similar to the Nestin-Cre mouse model (Lagace et al., 2007). Regardless, this study suggests subpopulation variability with respect to CoA synthase expression and opens novel insights regarding nucleus-mitochondria crosstalk relevant to age-variant onset Coasy-linked disorders.In the sensory system, Miwa et al. (2025) investigated a global axis between increased substrate consumption of N1-methylnicotinamide (MNAM), a byproduct of NAD + biosynthesis and inhibitor of nicotinamide N-methyltransferase (NNMT), Sirtuin 1 (protein: SIRT1, encoding gene: Sirt1, chr:10), an NAD-dependent transcription factor-deacetylase and effector of NNMT, and their relevance to age-related hearing loss in mouse cochlea. Mice were fed a lowfat diet (LFD) or a low-fat diet with 1% MNAM supplemented from postnatal week 4 and were analyzed for whole body biometrics, auditory brain stem responses, and cochlear metabolomic analysis at 3 months, 6 months, and 12 months of age. The authors report that LFD alone induced steady weight gain over 12 months, whereas LFD + MNAM-fed mice lost significant weight, observable by month 6, although there were no significant changes in blood biomarkers. LFD + MNAM mice also exhibited significant hearing loss by month 6, evident by the increased decibel threshold required to evoke auditory brainstem responses and outer hair cell dysfunction. Histological quantification revealed decreased hair cell number, decreased spiral ganglion cell number, and decreased cochlear turning. Sirt1 protein level was also increased in LFD + MNAM cochlea, and together with the metabolomics analysis of 6-monthold mice, demonstrates notable...


  • Open Access

    Mitochondrial therapeutics and mitochondrial transfer for neurodegenerative diseases and aging

    by Neville Ng, Michelle Newbery, Nicole Miles, Lezanne Ooi

    An abstract is unavailable. This article is available as a PDF only.


  • Open Access

    REST and RCOR genes display distinct expression profiles in neurons and astrocytes using 2D and 3D human pluripotent stem cell models

    by Simon Maksour, Neville Ng, Amy J. Hulme, Sara Miellet, Martin Engel, Sonia Sanz Muñoz, Rachelle Balez, Ben Rollo, Rocio K. Finol-Urdaneta, Lezanne Ooi, et al.

    Repressor element-1 silencing transcription factor (REST) is a transcriptional repressor involved in neurodevelopment and neuroprotection. REST forms a complex with the REST corepressors, CoREST1, CoREST2, or CoREST3 (encoded by RCOR1 , RCOR2 , and RCOR3 , respectively). Emerging evidence suggests that the CoREST family can target unique genes independently of REST, in various neural and glial cell types during different developmental stages. However, there is limited knowledge regarding the expression and function of the CoREST family in human neurodevelopment. To address this gap, we employed 2D and 3D human pluripotent stem cell (hPSC) models to investigate REST and RCOR gene expression levels. Our study revealed a significant increase in RCOR3 expression in glutamatergic cortical and GABAergic ventral forebrain neurons, as well as mature functional NGN2-induced neurons. Additionally, a simplified astrocyte transdifferentiation protocol resulted in a significant decrease in RCOR2 expression following differentiation. REST expression was notably reduced in mature neurons and cerebral organoids, along with RCOR2 in the latter. In summary, our findings provide the first insights into the cell-type-specific expression patterns of RCOR genes in human neuronal and glial differentiation. Specifically, RCOR3 expression increases in neurons, while RCOR2 levels decrease in astrocytes. The dynamic expression patterns of REST and RCOR genes during hPSC neuronal and glial differentiation underscore the potential distinct roles played by REST and CoREST proteins in regulating the development of these cell types in humans. Graphical Highlights: REST and RCOR genes display cell-type specific expression patterns in neural cells RCOR3 (encodes CoREST3) is upregulated during neuronal and astrocyte differentiation RCOR2 (encodes CoREST2) is downregulated during differentiation of astrocytes Evidence of potential cell-type specific functions of the CoREST family


  • Open Access

    Efficient third generation lentiviral particle production v4

    by Michelle Newbery, Simon Maksour, Amy Hulme, Neville S Ng, Mirella Dottori, Lezanne Ooi

    The overexpression of a gene of interest by third generation lentiviral particle generation systems is a critical process in molecular biology, cell biology and gene therapy research. While many lentiviral protocol production methods have been discussed in literature, this protocol takes into account previously established and novel optimisations to minimise user handling time, cost, and maximise practical yield. This protocol allows for at least 6 days of consecutive viral particle collection without compromising HEK293T cell culture or viral production efficiency, and can be easily and cost effectively reproduced in basic cell culture laboratories.


  • Open Access

    An Optimized Direct Lysis Gene Expression Microplate Assay and Applications for Disease, Differentiation, and Pharmacological Cell-Based Studies

    by Neville S. Ng, Simon Maksour, Jeremy S. Lum, Michelle Newbery, Victoria Shephard, Lezanne Ooi

    Routine cell culture reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) gene expression analysis is limited in scalability due to minimum sample requirement and multistep isolation procedures. In this study, we aimed to optimize and apply a cost-effective and rapid protocol for directly sampling gene expression data from microplate cell cultures. The optimized protocol involves direct lysis of microplate well population followed by a reduced thermocycler reaction time one-step RT-qPCR assay. In applications for inflammation and stress-induced cell-based models, the direct lysis RT-qPCR microplate assay was utilized to detect IFN1 and PPP1R15A expression by poly(I:C) treated primary fibroblast cultures, IL6 expression by poly(I:C) iPSC-derived astrocytes, and differential PPP1R15A expression by ER-stressed vanishing white-matter disease patient induced pluripotent stem cell (iPSC)-derived astrocytes. In application for neural differentiation medium recipe optimizations, conditions were screened for SYN1 and VGLUT1 in neuronal cultures, and S100B, GFAP and EAAT1 in astrocyte cultures. The protocol provides microplate gene expression results from cell lysate to readout within ~35 min, with comparable cost to routine RT-qPCR, and it may be utilized to support laboratory cell-based assays in basic and applied scientific and medical fields of research including stem-cell differentiation, cell physiology, and drug mechanism studies.


  • Open Access

    Transgene and Chemical Transdifferentiation of Somatic Cells for Rapid and Efficient Neurological Disease Cell Models

    by Neville Ng, Michelle Newbery, Simon Maksour, Mirella Dottori, Ronald Sluyter, Lezanne Ooi

    For neurological diseases, molecular and cellular research relies on the use of model systems to investigate disease processes and test potential therapeutics. The last decade has witnessed an increase in the number of studies using induced pluripotent stem cells to generate disease relevant cell types from patients. The reprogramming process permits the generation of a large number of cells but is potentially disadvantaged by introducing variability in clonal lines and the removal of phenotypes of aging, which are critical to understand neurodegenerative diseases. An under-utilized approach to disease modeling involves the transdifferentiation of aged cells from patients, such as fibroblasts or blood cells, into various neural cell types. In this review we discuss techniques used for rapid and efficient direct conversion to neural cell types. We examine the limitations and future perspectives of this rapidly advancing field that could improve neurological disease modeling and drug discovery.


  • Open Access

    Efficient third generation lentiviral particle production v3

    by Michelle Newbery, Simon Maksour, Amy Hulme, Neville S Ng, Mirella Dottori, Lezanne Ooi

    The overexpression of a gene of interest by third generation lentiviral particle generation systems is a critical process in molecular biology, cell biology and gene therapy research. While many lentiviral protocol production methods have been discussed in literature, this protocol takes into account previously established optimisations with the aim to minimise user handling time, cost, and maximise practical yield. This protocol allows for at least 6 days of consecutive viral particle collection without compromising HEK293T cell culture or viral production efficiency, and can be easily and cost effectively reproduced in basic cell culture laboratories.


  • Open Access

    Efficient third generation lentiviral particle production v2

    by Michelle Newbery, Simon Maksour, Amy Hulme, Neville S Ng, Mirella Dottori, Lezanne Ooi

    The overexpression of a gene of interest by third generation lentiviral particle generation systems is a critical process in molecular biology, cell biology and gene therapy research. While many lentiviral protocol production methods have been discussed in literature, this protocol takes into account previously established optimisations with the aim to minimise user handling time, cost, and maximise practical yield. This protocol allows for at least 6 days of consecutive viral particle collection without compromising HEK293T cell culture or viral production efficiency, and can be easily and cost effectively reproduced in basic cell culture laboratories.

  • Open Access

    Efficient third generation lentiviral particle production v1

    by Michelle Newbery, Neville S Ng, Simon Maksour, Amy Hulme, Mirella Dottori, Lezanne Ooi

    The overexpression of a gene of interest by third generation lentiviral particle generation systems have become a critical tool utilised in molecular biology, cell biology and gene therapy research. While many lentiviral protocol production methods have been discussed in literature, this protocol takes into account previously established optimisations with the aim to minimise user handling time and maximise practical yield. This protocol allows for at least 6 days of consecutive viral particle collection without compromising HEK293T cell culture or viral production efficiency, and can be easily and cost effectively reproduced in basic cell culture laboratories.


  • Open Access

    Identification of repurposable cytoprotective drugs for Vanishing White Matter Disease

    by Neville Ng, Mauricio Castro Cabral-Da-Silva, Simon Maksour, Tracey Berg, Martin Engel, Dina M. Silva, Dzung Do-Ha, Jeremy S. Lum, Sonia Sanz Muñoz, Nadia Suarez-Bosche, et al.

    Vanishing white matter disease (VWMD) is a rare leukodystrophy involving loss of function mutations of the guanine exchange factor eIF2B and typically presenting with juvenile onset. We aimed to identify repurposable FDA approved drugs in an in vitro drug screen using patient-derived fibroblasts and induced pluripotent stem cell (iPSC)-derived astrocytes. Dysregulated GADD34 and CHOP were identified in patient fibroblasts and iPSC-derived astrocytes under proteasomal stress conditions. A drug screen from a 2400 FDA approved drug library with EIF2B5 disease patient fibroblasts identified 113 anti-inflammatory drugs as a major class of hits with cytoprotective effects. A panel of potential candidate drugs including berberine, deflazacort, ursodiol, zileuton, guanabenz and Anavex 2-73, and preclinical ISRIB, increased cell survival of MG132-stressed EIF2B2 and EIF2B5 disease VWMD astrocytes, and were further investigated for their effect on the integrated stress response and mitochondrial stress. ISRIB but not other drugs significantly affected eIF2α phosphorylation and GADD34 expression. Ursodiol demonstrated capacity to reduce complex I subunit upregulation, ameliorate oxidative stress, loss of mitochondrial membrane potential and upregulation of eIF2B subunits in VWMD astrocytes, highlighting its potential as a cytoprotective compound for VWMD.